Itami, Japan

Atsuko Nishiguchi


 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Atsuko Nishiguchi: Innovator in Pharmaceutical Chemistry

Introduction

Atsuko Nishiguchi is a notable inventor based in Itami, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing complex chemical compounds. With a total of 2 patents to her name, her work has implications for both industrial production and medicinal applications.

Latest Patents

Nishiguchi's latest patents include a method for producing pyrrolidine compounds. This invention provides a production method suitable for the industrial production of (2S,3S)-3-amino-2-(3-bromo-2-fluorobenzyl)pyrrolidine, which features a protecting group at the 1-position. Additionally, she has developed a process for the preparation of optically active sulfonamides and intermediates for their synthesis. This method involves the resolution of a diastereomeric mixture, allowing for the production of diastereomers with specific steric configurations.

Career Highlights

Atsuko Nishiguchi is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Her work at Takeda has allowed her to focus on innovative solutions in drug development and production processes. Nishiguchi's expertise in chemical synthesis has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Nishiguchi has collaborated with esteemed colleagues, including Tomomi Ikemoto and Kiminori Tomimatsu. These collaborations have fostered a productive environment for research and innovation, contributing to the advancement of pharmaceutical sciences.

Conclusion

Atsuko Nishiguchi's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a key inventor in the industry. Her work continues to influence the development of new therapeutic compounds and production methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…